Synthekine is a development stage biotherapeutics company focused on the engineering of novel specific and potent cytokine therapies. Founded in 2018, Synthekine is backed by investors that include Canaan Partners, Samsara BioCapital, and The Column Group and is headquartered in Menlo Park.
FOUNDED:
2018
INDUSTRY:
Biotechnology, Therapeutics
You are seconds away from signing up for the hottest list in New York Tech!
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.
